Adherence to Long-Term Therapies - Evidence for Action
(2003; 211 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentAcknowledgements
View the documentScientific writers
View the documentIntroduction
View the documentTake-home messages
Close this folderSection I - Setting the scene
Open this folder and view contentsChapter I - Defining adherence
Open this folder and view contentsChapter II - The magnitude of the problem of poor adherence
Close this folderChapter III - How does poor adherence affect policy-makers and health managers?
View the document1. Diabetes
View the document2. Hypertension
View the document3. Asthma
View the document4. References
Open this folder and view contentsSection II - Improving adherence rates: guidance for countries
Open this folder and view contentsSection III - Disease-Specific Reviews
Open this folder and view contentsAnnexes
Open this folder and view contentsWhere to find a copy of this book
 

Chapter III - How does poor adherence affect policy-makers and health managers?

There is strong evidence that many patients with chronic illnesses including asthma, hypertension, diabetes and HIV/AIDS, have difficulty adhering to their recommended regimens. This results in less than optimal management and control of the illness. Poor adherence is the primary reason for suboptimal clinical benefit (1,2). It causes medical and psychosocial complications of disease, reduces patients' quality of life, and wastes health care resources. Taken together, these direct consequences impair the ability of health care systems around the world to achieve population health goals.

The conclusions of research in this area are unequivocal - adherence problems are observed in all situations where the self-administration of treatment is required, regardless of type of disease, disease severity and accessibility to health resources. While it may seem to be a simple issue, many factors contribute to adherence problems. Although some of these factors are patient-related, the characteristics of the disease and its treatment, and attributes of the health care system and service delivery also have great influence. Adherence problems have generally been overlooked by health stakeholders, and as a result have received little direct, systematic, intervention. Three prevalent chronic diseases, diabetes, hypertension and asthma provide compelling illustrations of different facets of these issues.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014